Advisory Services Network LLC Has $73,000 Holdings in Teleflex Incorporated (NYSE:TFX)

Advisory Services Network LLC boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 81.3% in the first quarter, according to its most recent filing with the SEC. The firm owned 243 shares of the medical technology company’s stock after acquiring an additional 109 shares during the period. Advisory Services Network LLC’s holdings in Teleflex were worth $73,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Quantamental Technologies LLC acquired a new stake in Teleflex during the 1st quarter worth $26,000. Meeder Asset Management Inc. acquired a new stake in Teleflex during the 1st quarter worth $31,000. Quadrant Capital Group LLC grew its holdings in Teleflex by 82.8% during the 1st quarter. Quadrant Capital Group LLC now owns 117 shares of the medical technology company’s stock worth $33,000 after acquiring an additional 53 shares during the period. Icon Wealth Partners LLC acquired a new stake in Teleflex during the 1st quarter worth $37,000. Finally, Financial Gravity Wealth Inc. acquired a new stake in Teleflex during the 1st quarter worth $52,000. 91.48% of the stock is owned by hedge funds and other institutional investors.

TFX has been the subject of a number of analyst reports. Needham & Company LLC lifted their target price on shares of CoStar Group from $500.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Wells Fargo & Co lowered shares of Dave & Buster’s Entertainment from an “outperform” rating to a “market perform” rating and set a $48.00 target price for the company. in a report on Tuesday, June 11th. UBS Group reaffirmed a “hold” rating on shares of Bayerische Motoren Werke in a report on Friday, March 22nd. Raymond James reaffirmed a “market perform” rating and set a C$43.00 target price on shares of Snc-Lavalin Group in a report on Wednesday, March 27th. Finally, Morgan Stanley lowered their target price on shares of Neon Therapeutics from $19.00 to $13.00 and set an “overweight” rating for the company in a report on Tuesday. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Teleflex has a consensus rating of “Buy” and an average target price of $333.75.

In related news, Director Benson Smith sold 8,500 shares of the firm’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $294.52, for a total transaction of $2,503,420.00. Following the transaction, the director now directly owns 85,300 shares of the company’s stock, valued at $25,122,556. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction dated Thursday, April 25th. The stock was sold at an average price of $277.14, for a total transaction of $55,428.00. Following the completion of the sale, the director now directly owns 589 shares in the company, valued at approximately $163,235.46. The disclosure for this sale can be found here. Insiders have sold a total of 54,949 shares of company stock worth $17,225,824 in the last quarter. 2.36% of the stock is currently owned by company insiders.

Shares of TFX stock traded down $5.43 on Friday, hitting $335.05. The stock had a trading volume of 185,700 shares, compared to its average volume of 353,381. The firm has a market cap of $15.42 billion, a price-to-earnings ratio of 33.84, a P/E/G ratio of 2.21 and a beta of 1.01. Teleflex Incorporated has a twelve month low of $226.02 and a twelve month high of $342.25. The company has a fifty day simple moving average of $322.16. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.41 and a current ratio of 2.27.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 2nd. The medical technology company reported $2.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.17 by $0.07. Teleflex had a net margin of 7.50% and a return on equity of 18.62%. The company had revenue of $613.60 million for the quarter, compared to analysts’ expectations of $608.27 million. During the same period in the prior year, the firm earned $2.15 EPS. Teleflex’s quarterly revenue was up 4.5% compared to the same quarter last year. Research analysts expect that Teleflex Incorporated will post 11.05 earnings per share for the current year.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

See Also: What causes a recession?

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.